secwatch.observer — SEC 8-K summary
======================================

Issuer:     Vivos Therapeutics, Inc. (VVOS)
CIK:        0001716166
Form:       8-K
Filed at:   2026-08-03T21:29:27+00:00
Accession:  0001493152-26-035867
Event type: leadership
Sentiment:  neutral
Materiality: 0.65
Item codes: 1.01, 5.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

CFO Bradford Amman resigns; Roman Franklin appointed CFO via CFO Portal effective July 31, 2026
--------------------------------------------------------------------------------

- Amman receives 250,000 fully vested shares, option for 150,000 shares, and $13,333/month advisory fee for 180 days.
- Franklin's CFO Portal gets $324,000 annual retainer plus $237,360 equity award; Franklin receives option for 552,000 shares.
- Amman remains as transition employee for 90 days at $320,000 salary, then as independent contractor for 180 days.
- If Company raises $5M+ equity, Amman's outstanding payments accelerate and options fully vest.
- No disagreement cited; Amman reaffirms restrictive covenants and mutual releases exchanged.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1716166/000149315226035867/0001493152-26-035867-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1716166/000149315226035867/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-26-035867

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer